Deals
Bradford Health Services, a US provider of addiction treatment programs, has acquired Cornerstone of Recovery, a Tennessee-based substance use disorder treatment provider. Bradford Health Services is backed by Centre Partners, a middle-market private equity firm focused on the consumer and healthcare sectors.
Butterfly, a Los Angeles-based private equity firm specialising in the food sector, is to partner with Chosen Foods (Chosen Foods), an industry leader and pioneer of avocado oil and creator of avocado-based kitchen staples including cooking sprays, mayonnaises, dressings, simmer sauces, guacamole, and salsa.
Butterfly will own a majority stake in the business. Terms of the transaction were not disclosed.
Butterfly has significant experience in food, across agriculture, aquaculture, food and beverage products, food distribution, and foodservice and its leadership team has been involved in investing more than USD10 billion of equity capital in companies ranging from growth-stage to Fortune
Accenture is to acquire King James Group, a creative agency with deep expertise in brand strategy, creativity and digital marketing services.
The move will strengthen Accenture Interactive’s focus on putting creativity at the center of experience-led transformation to drive relevance and growth for its clients.
“To succeed today, our clients must create unified brand experiences that make their customers’ lives easier and more meaningful. King James Group’s creativity and strength in driving marketing and communications that result in brand equity, will meet our clients’ demands for a single partner with seamless offerings across marketing, commerce and experience,” says Haydn Townsend,
The management team at musical instrument retailer GAK has completed a management buyout (MBO) following investment from Risk Capital Partners, with the support of specialist business advisory firm FRP.
Brighton-based GAK was founded in 1992 by CEO Gary Marshall, and is a leading musical instrument retailer, supplying a wide range of guitars, amps, drums, keyboards and music production software.
The business is now preparing for a period of growth, having been acquired by co-managing directors Max McKellar and Ian Stephens, with investment from Risk Capital Partners, which becomes the majority shareholder.
FRP Corporate Finance led the transaction, which will allow
Global law firm Paul Hastings has advised Intermediate Capital Group (ICG) on a comprehensive financing package to support its investment in Iver Holding AB alongside management and other shareholders.
Headquartered in Stockholm, the Iver group specialises in IT outsourcing and multi-cloud solutions.
The European leveraged finance team at Paul Hastings advised ICG on all aspects of the debt financing process, including the establishment of committed term and revolving facilities to support the ongoing growth and expansion of the Iver group.
A multi-disciplinary Paul Hastings team was led by London based finance partner Luke McDougall together with finance partner
Elvie, a global health and lifestyle brand developing products for women, has extended its Series C funding with a further GBP12.7 million (USD17.5 million) investment.
This investment – an extension to the initial Series C funding announced in July 2021 – takes Elvie’s total Series C to GBP70 million (USD97 million).
Founded in 2013 by CEO Tania Boler, Elvie brings together a team of world-class engineers, designers and business minds to develop extraordinary products that improve women’s lives – revolutionising categories which had been overlooked for many years, including breast pumps and pelvic floor health.
The Series C
Ogier has acted as British Virgin Islands counsel on NASDAQ-listed Kismet Acquisition One Corp’s merger with Cyprus-based Nexters Global Limited, in a SPAC business combination valuing Nexters at an enterprise value of USD1.9 billion.
The deal, initially signed at the end of January this year, closed on 27 August following the prior approval of Kismet’s shareholders.
The acquisition price was settled in a combination of shares in a new NASDAQ listed BVI company, Nexters Inc, which will hold the merged business, and an additional USD132 million in cash, which will effectively be reinvested in the business to develop new games
E&M Logistics (E&M), a US-based direct store delivery (DSD) distributors of ice cream, frozen and fresh foods, and beverages, has partnered with Mill Point Capital (Mill Point Capital), a middle-market private equity firm focused on control-oriented investments in the business services, industrials, and IT services sectors in North America.
The Mill Point team employs an Executive Partner model and has extensive experience investing in transactions in the distribution and business services sectors. For the E&M transaction, Jim Schubauer, an industry veteran with over 30 years of operating and management experience, will serve as Mill Point’s Executive Partner. Previously, Jim Schubauer
ILC Therapeutics, a UK-based biotechnology company and pioneer in the discovery and development of a ground-breaking new class of interferon drugs, has completed a GBP3.5 million pre-IPO funding round.
Investors include Los Angeles-based lawyer and investor, Robert Kopple; St Andrews-based Eos Angel Investment Syndicate; Scottish Enterprise; ILCT management.
Chairman Peter Bains says: “We are very pleased to complete this important funding round and to strengthen the Board with the appointment of Robert Kopple, Professor David Harrison and Chris Brinsmead. With this funding in place, ILCT is now well positioned to strengthen its novel technology platform and to advance its lead
contextflow, a provider of artificial intelligence for medical image analysis, has raised EUR6.7 million in a Series A funding round.
A second closing included an additional EUR2 million from new co-investor Peak Pride Management GmbH, HPH (Hans Peter Haselsteiner) Start-up Unit and current investor APEX Ventures with its “APEX Best in Class” fund. A first closing was led by B&C Innovation Investments GmbH (BCII) and included participation from new co-investor TTIP Beteiligungs GmbH and current investors APEX Ventures, Crista Galli Ventures, IST cube, Nina Capital and Novacapital.
The closing represents one of the largest Series A healthtech investments in Europe
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
